Larson Financial Group’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2K Sell
1,270
-91
-7% -$1.02K ﹤0.01% 2238
2026
Q1
$16.2K Buy
1,361
+401
+42% +$4.1K ﹤0.01% 1963
2025
Q4
$9.56K Buy
960
+934
+3,592% +$8.92K ﹤0.01% 2139
2025
Q3
$233 Sell
26
-3
-10% -$28 ﹤0.01% 3238
2025
Q2
$273 Buy
29
+21
+263% +$185 ﹤0.01% 2999
2025
Q1
$87 Hold
8
﹤0.01% 2937
2024
Q4
$76 Hold
8
﹤0.01% 2644
2024
Q3
$90 Hold
8
﹤0.01% 2550
2024
Q2
$80 Buy
+8
New +$81 ﹤0.01% 2289

Other funds holding AHCO

Larson Financial Group's AHCO Position: Q2 2026 in Review

Larson Financial Group reduced its AdaptHealth (AHCO) stake by 6.7% in Q2 2026, selling an estimated $1.02K and leaving 1,270 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2238.

Larson Financial Group first reported a position in AHCO in Q2 2024 and has held it in 9 quarters since. The position peaked at $16.2K in Q1 2026. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Larson Financial Group held 1,270 shares of AdaptHealth worth $13.2K as of Q2 2026.
  • Larson Financial Group sold 91 AdaptHealth shares in Q2 2026, an estimated $1.02K.
  • AdaptHealth made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2238 holding.
  • Larson Financial Group first reported a position in AdaptHealth in Q2 2024 and has held it in 9 quarters since.
  • Larson Financial Group's AdaptHealth position peaked at $16.2K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.